iqvia life scienc cloud busi continu soar
rais fve follow investor day
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jun
estim jun
price data jun
rate updat jun
currenc amount express
methodolog valu compani
rais fair valu estim iqvia per
share follow investor day june
manag laid strategi growth
well plan addit cost save
de-lever compani continu fire cylind
strong growth key segment technolog
analyt research develop continu
believ share look rich believ narrow-
moat compani competit well posit life
scienc technolog contract research space
compani unveil midterm guidanc guid
three-year revenu compound-annual-growth-rate adjust
ebitda growth higher
previous model manag also
review goal laid outset quintil
im health merger late includ mid-single-
digit revenu growth adjust ebitda growth
reduc net leverag time adjust ebitda
million merger cost synergi goal
met testament manag
execut robust oper environ within
biopharma space driven innov new drug
well solid fund biotech
new valuat larg driven faster revenu growth
technolog analyt research
develop one top contract research
organ world expect research
develop segment continu grow slightli faster
industri iqvia take share smaller
segment model revenu compound-annual-growth-rate
within manag guidanc
believ iqvia solut solut data
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
iqvia result merger quintil lead global contract
research organ im health lead healthcar data
analyt provid cro segment focus primarili provid
outsourc late-stag clinic trial pharmaceut devic
technolog servic client healthcar industri includ
pharmaceut compani provid payer policymak
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
icon health much debt use stock
repurchas averag repurchas price per share
sinc merger per share roughli
billion capit deploy sinc merger billion
use buy back share rest reinvest
busi use tuck-in acquisit
key target manag adjust ep growth
main pillar execut compens program along
adjust ebitda growth slightli lesser extent
revenu growth total sharehold return rel
peer think manag appropri
invest core busi believ stewardship could
improv rapid debt reduct
compani intend pace regardless reassur
compani confirm plan debt reduct
analyt real-world evid under-penetrated
model revenu compound-annual-growth-rate near
midpoint manag midterm guidanc
wide-moat veeva difficult displac life
scienc cloud solut iqvia hold advantag
uniqu dataset legaci im best-in-class
iqvia
establish relationship major biopharma
player whether data busi cro
busi last sever quarter iqvia
reinvest significantli oce offer
recent announc intent launch safety-rel
solut commerci complianc pharmacovigil
encroach veeva territori expect real-
world evid involv use real-world data
patient inform clinic trial design execut
even serv virtual arm trial continu slowli
gain traction industri iqvia best posit
benefit trend clinic trial given breadth
data analyt
compani also announc intent uncov
addit million cost save top
already-met goal million
materi affect fair valu estim alreadi
model margin improv next sever
year compar pure-play peer veeva
icon think iqvia room oper leaner level
addit compani guidanc signal intent
de-lever net leverag target time
adjust ebitda end compani end
gross debt billion net leverag
ratio time iqvia net leverag end
roughli par peer syneo health
took debt merger target time
less net leverag ratio peer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
